Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.
3.

Management of 'no-reflow' complicating reperfusion therapy.

Lee KW, Norell MS.

Acute Card Care. 2008;10(1):5-14. doi: 10.1080/17482940701744318. Review.

PMID:
18449813
5.

The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention.

Movahed MR, Butman SM.

Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):56-61. doi: 10.1016/j.carrev.2007.08.005. Review.

PMID:
18206640
6.

Percutaneous coronary intervention and the no-reflow phenomenon.

van Gaal WJ, Banning AP.

Expert Rev Cardiovasc Ther. 2007 Jul;5(4):715-31. Review.

PMID:
17605650
7.

Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.

Su Q, Nyi TS, Li L.

Cochrane Database Syst Rev. 2015 May 18;(5):CD009503. doi: 10.1002/14651858.CD009503.pub3. Review.

PMID:
25985145
8.

Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Singh M, Shah T, Khosla K, Singh P, Molnar J, Khosla S, Arora R.

Ther Adv Cardiovasc Dis. 2012 Jun;6(3):101-14. doi: 10.1177/1753944712446670. Epub 2012 May 4. Review.

PMID:
22562999

Supplemental Content

Support Center